Rare diseases
Investigational molecules
Locations
Testing WIN378 Safety and Effects in Adults with Moderate or Severe Asthma
SwedenA Study of BMS-986504 with Drug Combination Compared to Placebo with Drug Combination in Patients with Advanced Non-Small Cell Lung Cancer Starting First Treatment
SwedenStudy of rituximab followed by cladribine for patients with relapsing-remitting multiple sclerosis with less than 10 years disease duration
SwedenA Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia
SwedenA study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment
SwedenSwedenStudy of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy
SwedenStudy of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment
SwedenComparing brincidofovir and cidofovir for treating adenovirus infection in children and adults after stem cell transplantation
SwedenStudy of D-cycloserine with theta-burst brain stimulation for adults with major depressive disorder
SwedenStudy comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer
SwedenStudy of intraperitoneal paclitaxel combined with systemic therapy versus systemic therapy alone for patients with gastric cancer and peritoneal metastases
SwedenTell us about your condition – we search every trial in Europe and connect you with the right site.
